MADISON, Wis. (WFRV) — Wisconsin Attorney General Josh Kaul has joined a 44-state coalition in announcing a lawsuit against 20 of the nation’s largest generic drug manufacturers.
The lawsuit alleges a conspiracy to manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs, according to the Department of Justice.
“The complaint in this case alleges wide-ranging anti-competitive conduct that resulted in inflated prices for prescription drugs,” said Attorney General Kaul. “We must not allow unlawful pricing practices to increase the cost of health care.”
The complaint was originally filed in U.S. District Court for the District of Connecticut.
Twenty generic drug manufacturers, including Pfizer and Teva, are alleged to be engaging in the conspiracy. This includes the manufacturers fixing prices, allocating markets, and rigging bids for 147 drugs, according to the Wisconsin Department of Justice.
The lawsuit outlines a variety of different drugs involved, including tablets, creams, capsules, and other delivery systems which treat a range of diseases, including antibiotics, diabetes, cancer, and epilepsy.
Those participating in the complaint lay “out an interconnected web of industry executives where these competitors met with each other during industry dinners, lunches, cocktail parties, golf outings and communicated via frequent telephone calls, emails and text messages.”
According to officials, this is the second complaint filed in this investigation.
The first complaint, pending in the U.S. District Court in the Eastern District of Pennsylvania, was filed in 2016. It currently includes 18 corporate defendants and 15 generic drugs.